A2ML1 and breast carcinoma: As shown in Fig. S2, although the NPBWR1, A2ML1 and C4orf51 displayed differential expression, their expression level in breast cancer tissues is still not high (Figs. S2D–S2F), which may be due to their own expression abundance or sensitivity of the detection probe.